"CSU Treatment Expansion"
FDA Approval of Dupilumab for Chronic Spontaneous Urticaria
Transparency & Verification
Verified from Official SourcePolicy Pantry collects information from official and trusted public sources. Legislative information can change quickly. Always review the linked official government source for the most current details.
AI Plain-Language Summary
Click "Generate" to create an AI-powered plain-language summary of this legislation.
Summary
Expands the indication of dupilumab to include the treatment of chronic spontaneous urticaria (CSU) in patients 12 years and older uncontrolled by antihistamines.
Who This Bill Serves & Who's Backing It
Core Patient Populations
People with chronic spontaneous urticaria (hives).
Advocacy Groups Backing This Legislation
No advocacy organizations are currently tracked as backing this bill.Browse advocacy organizations →
Legislative Timeline
Votes & Legislative History
Airline Access to Emergency Epinephrine Act of 2015
Directs the FAA to require air carriers to carry epinephrine auto-injectors and train crew on anaphylaxis recognition and administration.
Protecting Children with Food Allergies Act
Requires school food service personnel in federally assisted meal programs to receive annual training on preventing, recognizing, and responding to food-related allergic reactions.
Alpha-gal Allergen Inclusion Act
Amends the Federal Food, Drug, and Cosmetic Act to add alpha-gal to the definition of major food allergen.
While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.